Alkylating agent combinations in the treatment of cancer
US8324282B2 · kind B2 · utility
14Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2003 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Sep 18, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This application provides compositions and methods useful in the treatment of certain cancers. In part, this application is based on the recognition that certain molecules that target abasic lesions or AP sites in DNA improve, augment, or potentiate the chemotherapeutic efficacy of certain anticancer agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.